Tome Biosciences is a biotechnology company that develops programmable gene insertion technology using CRISPR, allowing the insertion of any genetic sequence of any size at any location into any genome. The company focuses on cell and integrative gene therapies for patient care.

Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering.

BIO:TOME

Tome Biosciences

Analysis Not Available